首页> 外国专利> MODIFIED LEUKOCYTE IG-LIKE RECEPTOR FAMILY MEMBERS (LIR' S) WITH INCREASED AFFINITY FOR CLASS I MHC AND THEIR USES IN MODULATING T CELL ACTIVATION

MODIFIED LEUKOCYTE IG-LIKE RECEPTOR FAMILY MEMBERS (LIR' S) WITH INCREASED AFFINITY FOR CLASS I MHC AND THEIR USES IN MODULATING T CELL ACTIVATION

机译:I类MHC亲和力增强的改良白血病细胞IG类受体成员(LIR'S)及其在调节T细胞激活中的用途

摘要

The present invention provides polypeptides having the property of binding to a given Class I pMHC CHARACTERISED IN THAT said polypeptide has a KD for the said given Class I pMHC of less than or equal to lμM and/or has an off-rate (koff) for the said given Class I pMHC molecule of 2 S-1 or slower AND said polypeptide has at least a 45 % identity and/or 55 % similarity to SEQ ID NO: 7 AND said polypeptide inhibits CD8 binding to the given pMHC to a greater extent than the polypeptide SEQ ID NO: 3. Such polypeptides are useful, either alone or associated with a therapeutic agent, for the inhibition of cyto-toxic T cell (CTL) responses.
机译:本发明提供了具有与给定的I类pMHC结合的性质的多肽,其特征在于,所述多肽对于所述给定的I类pMHC的KD小于或等于1μM,和/或对于所述给定的I类2M-1或更慢的pMHC分子,并且所述多肽与SEQ ID NO:7具有至少45%的同一性和/或55%的相似性,并且所述多肽在更大程度上抑制CD8与给定的pMHC的结合这些多肽可单独或与治​​疗剂结合使用,以抑制细胞毒性T细胞(CTL)应答。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号